PACIRA BIOSCIENCES, INC. Discontinued Operation, Amounts of Material Contingent Liabilities Remaining
PACIRA BIOSCIENCES, INC. (PCRX) had Discontinued Operation, Amounts of Material Contingent Liabilities Remaining of $513.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes
us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining · last filed 2020-05-07
- 2020-03-31: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $513.00K.
- 2019-12-31: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $639.00K.
- 2019-09-30: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $756.00K.
- 2019-06-30: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $883.00K.
| Period end | Discontinued Operation, Amounts of Material Contingent Liabilities Remaining | Discontinued Operation, Amounts of Material Contingent Liabilities Remaining as first filed |
|---|---|---|
| 2020-03-31 | $513.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $639.00K 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $756.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $883.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $677.00K 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $2.25M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $2.08M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $1.16M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.31M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $2.08M 10-K · filed 2020-02-21 | $1.51M 10-K · filed 2018-02-28 |
| 2017-09-30 | $1.92M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.60M 10-Q · filed 2017-08-02 | |
| 2016-12-31 | $0.00 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |